This company listing is no longer active
RAP Stock Overview
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
ResApp Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.21 |
| 52 Week High | AU$0.21 |
| 52 Week Low | AU$0.048 |
| Beta | -0.42 |
| 1 Month Change | 10.67% |
| 3 Month Change | 18.57% |
| 1 Year Change | 156.17% |
| 3 Year Change | 3.75% |
| 5 Year Change | 200.73% |
| Change since IPO | 888.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| RAP | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 0.09% | 0.1% |
| 1Y | 156.2% | 117.3% | 6.2% |
Return vs Industry: RAP exceeded the Australian Healthcare Services industry which returned -22.6% over the past year.
Return vs Market: RAP exceeded the Australian Market which returned -8.2% over the past year.
Price Volatility
| RAP volatility | |
|---|---|
| RAP Average Weekly Movement | 17.1% |
| Healthcare Services Industry Average Movement | 11.4% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 4.0% |
Stable Share Price: RAP's share price has been volatile over the past 3 months.
Volatility Over Time: RAP's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Tony Keating | www.resapphealth.com.au |
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test; and SleepCheckRx, a smartphone application for at-home sleep apnoea screening. Its technology uses mathematical features for the diagnosis of pneumonia, asthma, and chronic obstructive pulmonary disease.
ResApp Health Limited Fundamentals Summary
| RAP fundamental statistics | |
|---|---|
| Market cap | AU$176.24m |
| Earnings (TTM) | -AU$7.10m |
| Revenue (TTM) | AU$3.81m |
Is RAP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAP income statement (TTM) | |
|---|---|
| Revenue | AU$3.81m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$3.81m |
| Other Expenses | AU$10.91m |
| Earnings | -AU$7.10m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0083 |
| Gross Margin | 100.00% |
| Net Profit Margin | -186.19% |
| Debt/Equity Ratio | 0% |
How did RAP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/09/16 12:25 |
| End of Day Share Price | 2022/09/15 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2022/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ResApp Health Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Scott Power | Morgans Financial Limited |